Parnax Lab revenue climbs 32% but profit stalls on rising costs
The pharma company hit ₹248.54 cr in annual revenue for FY26, yet net profit remained flat at ₹11.78 cr as operational expenses and labor-related charges weighed on the bottom line.
— 1 earlier story on Parnax Lab Ltd. →What's new
- Annual revenue reached ₹248.54 cr, up 32.4% from the prior year.
- Consolidated net profit stayed flat at ₹11.78 cr.
- Higher operational costs and labor code transition charges hit margins.
Why this matters
Top-line growth is failing to translate into bottom-line gains for this ₹174 cr market-cap firm. The stagnation in profit suggests that Parnax Lab is struggling to manage the cost of its own expansion.
What we're watching
- Whether the labor code transition costs are one-time or recurring.
- Margin recovery in the coming quarters.
- The impact of the independent director's re-appointment on governance.
The full read
Parnax Lab grew its annual revenue by 32.4% to ₹248.54 crore for the fiscal year ended March 31, 2026. Despite this top-line expansion, the company's consolidated net profit remained nearly flat at ₹11.78 crore.
Margins are suffering.
The disconnect between sales and earnings stems from higher operational costs and exceptional charges tied to labor code transitions. For a company with a market capitalization of just ₹174 crore, these rising costs are a clear drag on performance. While the revenue growth is a positive sign, the inability to scale profit alongside sales leaves the firm in a difficult position. The filing also included the routine re-appointment of an independent director, signaling no major changes to the board's composition. Investors are left with a mixed result: strong demand for products, but a business model that is currently struggling to protect its margins.
Questions answered
- How did Parnax Lab perform in FY26?
- The company grew its revenue by 32.4% to ₹248.54 crore. However, net profit remained stagnant at ₹11.78 crore.
- Why did profit fail to grow alongside revenue?
- Profit was held back by higher operational costs and exceptional charges related to labor code transitions.
- What is the market capitalization of Parnax Lab?
- The company is a nano-cap firm with a market capitalization of ₹174 crore.
- Were there any other corporate updates in the filing?
- Yes, the company confirmed the routine re-appointment of an independent director.
Story so far
All notes on PARNAXLAB →- 28 May 2026 · 10:39 PM IST Parnax Lab revenue climbs 32% but profit stalls on rising costs
- today Parnax Lab revenue climbs 32% to ₹248.54 crore in FY26